Yuji Uehara

Yuji Uehara

National Cancer Center - Tokyo / Japan
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5095517
国立がん研究センター
person_outline Yuji Uehara's MOST POPULAR ARTICLES
1-) Targeting the FGF/FGFR axis and its co-alteration allies ESMO open 7 (6), 100647, 2022
2-) Efficacy of first‐line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations Thoracic cancer 13 (11), 1703-1711, 2022
3-) Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in … Translational Lung Cancer Research 11 (2), 135, 2022
4-) Travel time and distance and participation in precision oncology trials at the National Cancer Center Hospital JAMA Network Open 6 (9), e2333188-e2333188, 2023
5-) Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR … ESMO Real World Data and Digital Oncology 5, 100058, 2024